NASDAQ : ALGN

Align Technology, Inc.

$176.76 USD

-$1.65 (-0.92%)

Volume
811.39K
Average Volume
1.06M
Market Capitalization
$12.66B
P/E Ratio
29.61
Dividend Yield
0.00%
Price Target
$200.00
Year High
$208.31
Year Low
$122.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.39
Source Headline
Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year

Over six years, Align has contributed more than $2M to Operation Smile's student programs to send the next generation of global health advocates to the world stage VIRGINIA BEACH, Va., and TEMPE, Ariz.

prnewswire.com - 2026-07-14 09:00:00

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

zacks.com - 2026-07-14 04:36:12

5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

zacks.com - 2026-07-13 13:40:24

ALGN vs. SAUHY: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Align Technology (ALGN) and Straumann Holding AG (SAUHY). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-07-13 12:41:05

Here's Why Align Technology (ALGN) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-07-13 10:40:42

Here Are Thursday's Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, Toast, and More

Futures are trading mixed after another tough day across Wall Street, with all the major indices crushed early on, before the Nasdaq made a late-afternoon push to wind up just modestly higher at 25,870, up 0.20%.

247wallst.com - 2026-07-09 07:52:34

This Align Technology Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

benzinga.com - 2026-07-09 07:51:10

Align Technology to Announce Second Quarter 2026 Results on July 29, 2026

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2026 financial results on Wednesday, July 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and wil.

businesswire.com - 2026-07-01 08:30:00

Align Technology Statement on European Commission Proceeding

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today responded to the European Commission's June 30 press release announcing an investigation involving the Company based on a complaint made by an Align competitor. Align Technology is comm.

businesswire.com - 2026-06-30 20:21:00

ALGN or SAUHY: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com - 2026-06-25 12:40:13

Here's Why Align Technology (ALGN) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-25 10:41:20

Here's Why Align Technology (ALGN) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-24 10:50:37

Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that C. Raymond Larkin, Jr. will retire as Chairman of the Board effective July 1, 2026, following more than 20 years of distinguished service on Align's Board of Directors. M.

businesswire.com - 2026-06-18 21:01:00

Align Technology (ALGN) Just Overtook the 50-Day Moving Average

After reaching an important support level, Align Technology (ALGN) could be a good stock pick from a technical perspective. ALGN surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.

zacks.com - 2026-06-10 10:31:10

Align Technology, Inc. (ALGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Align Technology, Inc. (ALGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-08 12:18:30

Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure

Align Technology NASDAQ: ALGN CFO John Morici said the company continues to navigate a challenging but stable demand environment, with international markets and dental service organizations offsetting pressure in parts of North America.

marketbeat.com - 2026-06-04 22:04:03

Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-04 14:32:55

Align Technology, Inc. (ALGN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

Align Technology, Inc. (ALGN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

seekingalpha.com - 2026-06-03 15:41:59

Align Technology Pitches AI-Powered Digital Dentistry Platform Beyond Invisalign

Align Technology NASDAQ: ALGN executives used a William Blair investor presentation to emphasize the company's broader digital dentistry platform, positioning Invisalign as part of a workflow that spans consumer engagement, scanning, treatment planning, monitoring and retention.

marketbeat.com - 2026-06-03 12:02:31

Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of twelve research grants to universities under the company's fifteenth Annual Research Award Program. “Research and clinical evidence continue to be at the core of.

businesswire.com - 2026-06-01 16:00:00

Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-29 12:32:09

Align Technology Highlights New Invisalign Solutions, Financing and Global Growth

Align Technology NASDAQ: ALGN executives highlighted product innovation, financing initiatives and international expansion as key growth drivers during a discussion at the 2026 Stifel Jaws & Paws Conference.

marketbeat.com - 2026-05-28 13:08:00

Align Technology, Inc. (ALGN) Presents at Stifel Jaws & Paws Conference 2026 Transcript

Align Technology, Inc. (ALGN) Presents at Stifel Jaws & Paws Conference 2026 Transcript

seekingalpha.com - 2026-05-28 11:54:22

Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?

CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.

zacks.com - 2026-05-25 12:16:05

Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India

HYDERABAD, India & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced plans to open a new manufacturing facility in Hyderabad, India in 2027, create more than 300 direct jobs, and spend approximately $200 million in both ca.

businesswire.com - 2026-05-22 16:10:00

Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?

Here is how Align Technology (ALGN) and Carlsmed, Inc. (CARL) have performed compared to their sector so far this year.

zacks.com - 2026-05-22 10:41:21

Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations

BARCELONA, Spain & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East.

businesswire.com - 2026-05-21 16:40:00

A Look at Align Technology Inc (ALGN) After 5.3% Gain -- GF Value $238.92 vs Price $163.42

On May 20, 2026, Align Technology Inc (ALGN) shares rose 5.3% today, closing at $163.42. The stock has been trading in a 52-week range from a low of $122.00 to

gurufocus.com - 2026-05-20 19:14:00

Align Technology to Speak at Upcoming Financial Conferences

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Te.

businesswire.com - 2026-05-20 16:01:00

Reasons to Add Align Technology Stock to Your Portfolio Now

ALGN expands Invisalign worldwide and iTero Lumina leads scanner mix, backed by $1.06B cash, yet 2026 ASP expected down 1-2%.

zacks.com - 2026-05-20 15:35:49

Why Align Technology (ALGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-05-18 10:40:37

ALGN vs. WST: Which Stock Is the Better Value Option?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-05-11 12:41:15

What Makes Align Technology (ALGN) a New Buy Stock

Align Technology (ALGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com - 2026-05-06 13:01:12

Align Technology Announces $200 Million Open Market Repurchase

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200.0 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved.

businesswire.com - 2026-05-01 05:55:00

Align Technology Showcases Latest Advances in Integrated Digital Orthodontics and Previews 2026 Innovation at AAO Annual Session

ORLANDO, Fla. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared a preview of what orthodontists and their teams can expect from the Company (booth #1643) during the American Association of Orthodontists (AAO) 2026 Annual Session, taking.

businesswire.com - 2026-04-30 14:55:00

ALGN Stock Up Post Q1 Earnings and Revenue Beat, Margins Rise

Align Technology jumps after Q1 earnings beat as record Invisalign shipments, rising margins and steady global demand drive solid revenue growth.

zacks.com - 2026-04-30 14:11:21

Align Technology Inc (ALGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Global Challenges

Total Revenue: $1.041 billion, up 6.2% year-over-year.Clear Aligner Revenue: $856 million, up 7.4% year-over-year.Systems and Services Revenue: $184 million, u

gurufocus.com - 2026-04-30 02:17:00

Align Technology, Inc. (ALGN) Q1 2026 Earnings Call Transcript

Align Technology, Inc. (ALGN) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-29 21:31:33

Align Technology (ALGN) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Align Technology (ALGN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-04-29 19:31:08

Align Technology (ALGN) Q1 Earnings and Revenues Surpass Estimates

Align Technology (ALGN) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.13 per share a year ago.

zacks.com - 2026-04-29 18:47:49

Align Technology beats quarterly estimates, plans $200 million buyback

Align Technology beat Wall Street estimates for first-quarter profit, aided by strong demand for its dental aligners, ​and announced a $200 million share buyback program, sending ‌shares up as much as 4% in after-market trading.

reuters.com - 2026-04-29 18:00:32

Align Technology Announces First Quarter 2026 Financial Results, $200M Stock Repurchase, and Reaffirms Fiscal 2026 Guidance

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'26"). Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year. Q1'26 total revenues were favorably impa.

businesswire.com - 2026-04-29 16:05:00

Here's Why Align Technology (ALGN) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-04-29 10:41:20

Here's Why Align Technology (ALGN) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-04-24 10:51:58

Align Technology's Q1 Earnings on Deck: Here's What to Expect

ALGN's Q1 report looms with revenues seen rising 4.3% and EPS up 6.1%, as Invisalign demand and iTero adoption drive growth trends.

zacks.com - 2026-04-21 12:35:13

Sumitomo Mitsui Trust Group Inc. Sells 151,437 Shares of Align Technology, Inc. $ALGN

Sumitomo Mitsui Trust Group Inc. lessened its position in Align Technology, Inc. (NASDAQ: ALGN) by 84.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,169 shares of the medical equipment provider's stock after selling 151,437 shares during the quarter. Sumitomo Mitsui

defenseworld.net - 2026-04-19 05:07:27

Get ALGN Insider Trade Alerts

ALGN Price Target Summary

Last Month

$209.00

1 analysts

Last Quarter

$210.67

3 analysts

Last Year

$190.61

23 analysts

All Time

$298.17

47 analysts

ALGN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-04-30 Evercore ISI Group Maintain Outperform Outperform
2026-04-24 Morgan Stanley Maintain Equal Weight Equal Weight
2026-04-21 Piper Sandler Maintain Overweight Overweight
2026-03-17 Barclays Upgrade Equal Weight Overweight
2026-02-26 Barclays Maintain Equal Weight Equal Weight
2026-02-09 HSBC Upgrade Hold Buy
2026-02-05 Morgan Stanley Maintain Equal Weight Equal Weight
2026-02-05 Wells Fargo Maintain Overweight Overweight
2026-02-05 Stifel Maintain Buy Buy
2026-02-05 UBS Maintain Neutral Neutral
2026-02-05 Piper Sandler Maintain Overweight Overweight
2026-02-05 Evercore ISI Group Maintain Outperform Outperform
2026-01-20 Mizuho Maintain Outperform Outperform
2025-10-30 Wells Fargo Maintain Overweight Overweight
2025-10-30 Evercore ISI Group Maintain Outperform Outperform
2025-10-30 Piper Sandler Maintain Overweight Overweight
2025-10-30 Morgan Stanley Maintain Equal Weight Equal Weight
2025-10-21 Morgan Stanley Maintain Equal Weight Equal Weight
2025-10-16 UBS Maintain Neutral Neutral
2025-10-13 Mizuho Maintain Outperform Outperform
2025-10-10 Jefferies Downgrade Buy Hold
2025-10-08 Evercore ISI Group Maintain Outperform Outperform
2025-07-31 Stifel Maintain Buy Buy
2025-07-31 Wells Fargo Maintain Overweight Overweight
2025-07-31 Piper Sandler Maintain Overweight Overweight
2025-07-31 Morgan Stanley Downgrade Overweight Equal Weight
2025-07-09 Evercore ISI Group Maintain Outperform Outperform
2025-05-01 Wells Fargo Maintain Overweight Overweight
2025-05-01 Needham Maintain Hold Hold
2025-05-01 Piper Sandler Maintain Overweight Overweight
2025-05-01 Evercore ISI Group Maintain Outperform Outperform
2025-04-29 Mizuho Maintain Outperform Outperform
2025-04-25 HSBC Downgrade Buy Hold
2025-04-24 UBS Maintain Neutral Neutral
2025-04-15 Morgan Stanley Maintain Overweight Overweight
2025-03-25 Mizuho Maintain Outperform Outperform
2025-03-18 Piper Sandler Maintain Overweight Overweight
2025-02-06 Evercore ISI Group Maintain Outperform Outperform
2025-02-06 Piper Sandler Maintain Overweight Overweight
2025-02-06 Morgan Stanley Maintain Overweight Overweight
2025-02-06 Needham Maintain Hold Hold
2025-01-23 Jefferies Maintain Buy Buy
2025-01-06 Leerink Partners Upgrade Market Perform Outperform
2024-12-13 B of A Securities Maintain Underperform Underperform
2024-10-24 Piper Sandler Maintain Overweight Overweight
2024-10-24 Baird Maintain Outperform Outperform
2024-10-24 Evercore ISI Group Maintain Outperform Outperform
2024-10-24 Morgan Stanley Maintain Overweight Overweight
2024-10-24 Stifel Maintain Buy Buy
2024-10-17 Piper Sandler Maintain Overweight Overweight
2024-10-11 Stifel Maintain Buy Buy
2024-10-08 Evercore ISI Group Maintain Outperform Outperform
2024-09-13 Piper Sandler Maintain Overweight Overweight
2024-07-25 Piper Sandler Maintain Overweight Overweight
2024-07-25 Stifel Maintain Buy Buy
2024-07-25 Morgan Stanley Maintain Overweight Overweight
2024-07-22 Baird Maintain Outperform Outperform
2024-07-10 Piper Sandler Maintain Overweight Overweight
2024-06-21 Piper Sandler Maintain Overweight Overweight
2024-06-10 Evercore ISI Group Maintain Outperform Outperform
2024-06-04 OTR Global Downgrade Positive Mixed
2024-04-25 Morgan Stanley Maintain Overweight Overweight
2024-04-25 Piper Sandler Maintain Overweight Overweight
2024-04-25 Baird Maintain Outperform Outperform
2024-04-18 Stifel Maintain Buy Buy
2024-04-15 UBS Maintain Neutral Neutral
2024-03-15 Stifel Maintain Buy Buy
2024-03-13 Piper Sandler Maintain Overweight Overweight
2024-02-02 Goldman Sachs Maintain Sell Sell
2024-02-01 UBS Maintain Neutral Neutral
2024-02-01 Piper Sandler Maintain Overweight Overweight
2024-01-30 UBS Maintain Neutral Neutral
2023-12-11 Goldman Sachs Downgrade Neutral Sell
2023-10-27 Piper Sandler Maintain Overweight Overweight
2023-10-27 UBS Downgrade Buy Neutral
2023-10-26 Morgan Stanley Maintain Overweight Overweight
2023-10-26 Stifel Maintain Buy Buy
2023-10-26 Piper Sandler Maintain Overweight Overweight
2023-10-24 Stifel Maintain Buy Buy
2023-09-14 OTR Global Upgrade Mixed Positive
2023-08-24 Stifel Maintain Buy Buy
2023-07-27 Goldman Sachs Maintain Neutral Neutral
2023-07-27 Morgan Stanley Maintain Overweight Overweight
2023-04-28 Goldman Sachs Maintain Neutral Neutral
2023-04-27 B of A Securities Maintain Underperform Underperform
2023-04-27 Piper Sandler Maintain Overweight Overweight
2023-04-19 Morgan Stanley Maintain Overweight Overweight
2023-04-18 Stifel Maintain Buy Buy
2023-03-31 OTR Global Upgrade Mixed Positive
2023-02-03 Goldman Sachs Upgrade Sell Neutral
2023-02-02 Piper Sandler Maintain Overweight Overweight
2023-02-02 Stifel Maintain Buy Buy
2023-02-02 Goldman Sachs Upgrade Sell Neutral
2023-02-02 Baird Maintain Outperform Outperform
2023-02-02 Evercore ISI Group Maintain Outperform Outperform
2023-01-11 Piper Sandler Maintain Overweight Overweight
2022-10-27 Baird Maintain Outperform Outperform
2022-10-27 Goldman Sachs Maintain Sell Sell
2022-10-27 Piper Sandler Maintain Overweight Overweight
2022-10-27 Stifel Maintain Buy Buy
2022-10-27 Morgan Stanley Maintain Overweight Overweight
2022-10-17 B of A Securities Maintain Underperform Underperform
2022-10-13 Piper Sandler Maintain Overweight Overweight
2022-10-12 Stifel Maintain Buy Buy
2022-09-09 Piper Sandler Maintain Overweight Overweight
2022-07-29 UBS Maintain Buy Buy
2022-07-28 Stephens & Co. Maintain Overweight Overweight
2022-07-28 Morgan Stanley Maintain Overweight Overweight
2022-07-28 B of A Securities Maintain Underperform Underperform
2022-07-28 Baird Maintain Outperform Outperform
2022-07-28 Evercore ISI Group Maintain Outperform Outperform
2022-07-28 Goldman Sachs Downgrade Buy Sell
2022-07-22 Piper Sandler Maintain Overweight Overweight
2022-07-20 Morgan Stanley Maintain Overweight Overweight
2022-07-18 UBS Maintain Buy Buy
2022-07-14 Stifel Maintain Buy Buy
2022-06-15 Morgan Stanley Maintain Overweight Overweight
2022-05-04 Credit Suisse Maintain Outperform Outperform
2022-05-03 UBS Maintain Buy Buy
2022-04-28 Piper Sandler Maintain Overweight Overweight
2022-04-28 Stifel Maintain Buy Buy
2022-04-28 Baird Maintain Outperform Outperform
2022-04-28 Morgan Stanley Maintain Overweight Overweight
2022-04-26 UBS Maintain Buy Buy
2022-04-21 Piper Sandler Maintain Overweight Overweight
2022-04-12 Evercore ISI Group Maintain Outperform Outperform
2022-02-03 Stifel Maintain Buy Buy
2022-02-03 B of A Securities Maintain Underperform Underperform
2022-02-03 Credit Suisse Maintain Outperform Outperform
2022-01-31 UBS Upgrade Neutral Buy
2022-01-31 Morgan Stanley Maintain Overweight Overweight
2021-11-11 UBS Maintain Neutral Neutral
2021-10-28 Piper Sandler Maintain Overweight Overweight
2021-10-28 Evercore ISI Group Maintain Outperform Outperform
2021-07-29 Piper Sandler Maintain Overweight Overweight
2021-07-29 Wolfe Research Maintain Outperform Outperform
2021-07-29 Credit Suisse Maintain Outperform Outperform
2021-07-09 Stephens & Co. Upgrade Equal Weight Overweight
2021-07-08 BNP Paribas Maintain Outperform Outperform
2021-05-14 Stephens & Co. Maintain Equal Weight Equal Weight
2021-04-29 SVB Leerink Maintain Outperform Outperform
2021-04-29 Piper Sandler Maintain Overweight Overweight
2021-04-29 Credit Suisse Maintain Outperform Outperform
2021-04-29 Stifel Maintain Buy Buy
2021-04-22 Berenberg Upgrade Hold Buy
2021-04-15 SVB Leerink Maintain Outperform Outperform
2021-02-09 Wolfe Research Maintain Outperform Outperform
2021-02-04 SVB Leerink Maintain Outperform Outperform
2021-02-04 Piper Sandler Maintain Overweight Overweight
2021-02-04 Credit Suisse Maintain Outperform Outperform
2021-02-04 Evercore ISI Group Maintain Outperform Outperform
2021-02-04 Barclays Maintain Equal Weight Equal Weight
2021-02-02 Piper Sandler Maintain Overweight Overweight
2021-02-01 Goldman Sachs Maintain Buy Buy
2021-01-27 UBS Maintain Neutral Neutral
2021-01-04 Wolfe Research Maintain Outperform Outperform
2021-01-04 Evercore ISI Group Upgrade In Line Outperform
2020-11-24 Credit Suisse Maintain Outperform Outperform
2020-11-24 SVB Leerink Maintain Outperform Outperform
2020-10-28 Stifel Maintain Buy Buy
2020-10-23 UBS Maintain Neutral Neutral
2020-10-23 Goldman Sachs Maintain Buy Buy
2020-10-22 Piper Sandler Maintain Overweight Overweight
2020-10-22 Stifel Maintain Buy Buy
2020-10-22 Credit Suisse Maintain Outperform Outperform
2020-10-22 Stephens & Co. Maintain Equal Weight Equal Weight
2020-10-22 Baird Maintain Outperform Outperform
2020-10-22 Jefferies Maintain Buy Buy
2020-10-22 Barclays Maintain Equal Weight Equal Weight
2020-10-22 SVB Leerink Maintain Outperform Outperform
2020-07-29 Berenberg Downgrade Buy Hold
2020-07-23 Barclays Downgrade Overweight Equal Weight
2020-07-23 SVB Leerink Maintain Outperform Outperform
2020-07-23 Goldman Sachs Maintain Buy Buy
2020-07-23 Piper Sandler Maintain Overweight Overweight
2020-07-20 B of A Securities Downgrade Neutral Underperform
2020-07-17 Stifel Maintain Buy Buy
2020-07-14 SVB Leerink Maintain Outperform Outperform
2020-06-12 Stifel Maintain Buy Buy
2020-06-10 Baird Maintain Outperform Outperform
2020-05-22 Stifel Maintain Buy Buy
2020-05-01 UBS Maintain Neutral Neutral
2020-04-30 Credit Suisse Maintain Outperform Outperform
2020-03-19 Stephens & Co. Maintain Equal Weight Equal Weight
2020-03-13 Stifel Maintain Buy Buy
2020-01-31 UBS Maintain Neutral Neutral
2020-01-28 UBS Maintain Neutral Neutral
2020-01-02 Baird Maintain Outperform Outperform
2019-11-18 Stifel Maintain Buy Buy
2019-10-07 Barclays Maintain Overweight Overweight
2019-07-26 Baird Maintain Outperform Outperform
2019-07-25 Evercore ISI Group Downgrade Outperform In Line
2019-04-25 Barclays Maintain Overweight Overweight
2019-04-18 Guggenheim Maintain Buy Buy
2019-03-05 Baird Maintain Outperform Outperform
2019-02-14 UBS Downgrade Buy Neutral
2019-01-17 UBS Maintain Buy Buy
2019-01-04 Morgan Stanley Maintain Equal Weight Equal Weight
2018-11-20 Credit Suisse Maintain Outperform Outperform
2018-10-25 Morgan Stanley Maintain Equal Weight Equal Weight
2018-10-25 Baird Maintain Outperform Outperform
2018-10-25 Credit Suisse Maintain Outperform Outperform
2018-10-09 Morgan Stanley Maintain Equal Weight Equal Weight
2018-07-26 Credit Suisse Maintain Outperform Outperform
2018-07-26 Stifel Maintain Buy Buy
2018-07-26 Stifel Nicolaus Maintain Buy Buy
2018-07-13 Morgan Stanley Maintain Equal Weight Equal Weight
2018-07-13 Stifel Maintain Buy Buy
2018-07-13 Stifel Nicolaus Maintain Buy Buy
2018-05-25 Credit Suisse Maintain Outperform Outperform
2018-05-24 Piper Sandler Maintain Overweight Overweight
2018-05-24 Leerink Swann Maintain Outperform Outperform
2018-05-24 PiperJaffray Maintain Overweight Overweight
2018-05-22 Stifel Maintain Buy Buy
2018-05-22 Stifel Nicolaus Maintain Buy Buy
2018-05-21 Barclays Maintain Overweight Overweight
2018-05-17 Evercore ISI Group Maintain Outperform Outperform
2018-04-26 Barclays Maintain Overweight Overweight
2018-04-26 Morgan Stanley Maintain Equal Weight Equal Weight
2018-04-26 Stifel Maintain Buy Buy
2018-04-26 Stifel Nicolaus Maintain Buy Buy
2018-04-26 Credit Suisse Maintain Outperform Outperform
2018-04-20 Berenberg Maintain Buy Buy
2018-04-19 Morgan Stanley Downgrade Overweight Equal Weight
2018-03-08 Barclays Maintain Overweight Overweight
2018-01-31 Credit Suisse Maintain Outperform Outperform
2018-01-31 Leerink Swann Maintain Outperform Outperform
2018-01-30 Stifel Nicolaus Maintain Buy Buy
2018-01-30 Stifel Maintain Buy Buy
2018-01-19 Stephens & Co. Downgrade Overweight Equal Weight
2017-12-08 Deutsche Bank Maintain Hold Hold
2017-10-27 Stifel Nicolaus Maintain Buy Buy
2017-10-27 Credit Suisse Maintain Outperform Outperform
2017-10-27 Stifel Maintain Buy Buy
2017-10-23 Stifel Nicolaus Maintain Buy Buy
2017-10-23 Stifel Maintain Buy Buy
2017-10-06 Morgan Stanley Maintain Overweight Overweight
2017-07-28 Bank of America Upgrade Neutral Buy
2017-07-28 B of A Securities Upgrade Neutral Buy
2017-07-28 Leerink Swann Maintain Outperform Outperform
2017-07-17 Morgan Stanley Maintain Overweight Overweight
2017-04-28 Baird Upgrade Neutral Outperform
2016-11-28 Stifel Nicolaus Maintain Buy Buy
2016-11-28 Stifel Maintain Buy Buy
2016-10-03 Baird Downgrade Overweight Neutral
2016-07-28 Stifel Maintain Buy Buy
2016-07-28 Stifel Nicolaus Maintain Buy Buy
2016-05-11 Credit Suisse Maintain Outperform Outperform
2016-03-23 Roth Capital Maintain Buy Buy
2015-11-18 PiperJaffray Maintain Overweight Overweight
2015-10-23 Jefferies Maintain Buy Buy
2015-07-24 Stifel Nicolaus Maintain Buy Buy
2015-07-24 Stifel Maintain Buy Buy
2015-04-21 Morgan Stanley Upgrade Equal Weight Overweight
2015-01-30 Jefferies Maintain Buy Buy
2015-01-30 JMP Securities Downgrade Market Outperform Market Perform
2015-01-02 Baird Upgrade Neutral Outperform
2014-10-20 Credit Suisse Upgrade Neutral Outperform
2014-10-20 Goldman Sachs Upgrade Neutral Buy
2014-07-25 Jefferies Maintain Hold Hold
2014-04-24 Credit Suisse Maintain Neutral Neutral
2014-04-07 Barrington Research Upgrade Market Perform Outperform
2014-01-29 Stifel Maintain Buy Buy
2014-01-29 Stifel Nicolaus Maintain Buy Buy
2013-10-18 Cantor Fitzgerald Upgrade Hold Buy
2013-10-04 Baird Downgrade Outperform Neutral
2013-09-17 Stifel Maintain Buy Buy
2013-09-17 Stifel Nicolaus Maintain Buy Buy
2013-07-10 Stifel Nicolaus Maintain Buy Buy
2013-07-10 Stifel Maintain Buy Buy
2013-07-01 Baird Maintain Outperform Outperform
2013-06-17 Stifel Maintain Buy Buy
2013-06-17 Stifel Nicolaus Maintain Buy Buy
2013-05-28 Jefferies Downgrade Buy Hold
2013-05-20 Barrington Research Downgrade Outperform Market Perform
2013-02-04 Stifel Nicolaus Maintain Buy Buy
2013-02-04 Stifel Maintain Buy Buy
2013-01-31 Jefferies Maintain Buy Buy
2013-01-31 Stephens & Co. Upgrade Equal Weight Overweight
2013-01-29 Janney Capital Maintain Buy Buy
2013-01-03 Morgan Stanley Upgrade Underperform Equal Weight
2012-12-11 Goldman Sachs Maintain Neutral Neutral
2012-12-06 Cantor Fitzgerald Maintain Hold Hold
2012-11-08 Stifel Nicolaus Maintain Buy Buy
2012-10-18 Cantor Fitzgerald Maintain Hold Hold
2012-10-18 Jefferies Maintain Buy Buy
2012-07-20 Jefferies Maintain Buy Buy
2012-05-22 Cantor Fitzgerald Maintain Buy Buy
2012-04-25 Barrington Research Maintain Outperform Outperform
2012-04-24 Jefferies Maintain Buy Buy
2012-02-27 Morgan Stanley Maintain Underweight Underweight